2018 Stanford Drug Discovery Conference

Introduction and Welcome Address

Preview Available

Introduction and Welcome Address

• Joseph C. Wu, MD, PhD, Stanford Cardiovascular Institute
• Lloyd Minor, MD, Stanford University School of Medicine
• David Entwistle, MHSA
• Dennis Lund, MD

Regulatory Science in Academia: Advancing Drug Development

Preview Available

Regulatory Science in Academia: Advancing Drug Development

• Kathleen Giacomini, PhD, UCSF School of Medicine

Chemical Tricks for Drugging the Undruggable

Preview Available

Chemical Tricks for Drugging the Undruggable

• Kevan Shokat, PhD, UCSF School of Medicine

Intelligent Intervention: Ozanimod from hit to NCE at Scripps

Preview Available

Intelligent Intervention: Ozanimod from hit to NCE at Scripps

• Hugh Rosen, MD, PhD, Scripps Research Institute

Treating Disease by Manipulating the Immune System

Preview Available

Treating Disease by Manipulating the Immune System

• Edgar Engleman, MD, Stanford University School of Medicine

Inventing for Life: the CEO Perspective

Preview Available

Inventing for Life: the CEO Perspective

• Ken Frazier, JD, Merch & Co., Inc.

Outcomes Based Pricing

Preview Available

Outcomes Based Pricing

• Joe Jimenez, MBA

Patient as the Biological Factory of the Future

Preview Available

Patient as the Biological Factory of the Future

• Patrick Soon-Shiong, MD, NantWorks

Using the Innovation Ecosystem to Build a Robust Pipeline

Preview Available

Using the Innovation Ecosystem to Build a Robust Pipeline

• Brent Saunders, MBA, JD, Allergan

Philanthropy's Vital Role in Partnering with Healthcare

Preview Available

Philanthropy's Vital Role in Partnering with Healthcare

• Sanford Weill, Citigroup